PET/CT imaging of clear cell renal cell carcinoma with I labeled chimeric antibody.


Clear cell renal cell carcinoma (ccRCC) presents problems for urologists in diagnosis, treatment selection, intraoperative surgical margin analysis, and long term monitoring. In this paper we describe the development of a radiolabeled antibody specific to ccRCC (124I-cG250) and its potential to help urologists manage each of these problems. We believe 124I… (More)
DOI: 10.1177/1756287209105264